Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16902173rdf:typepubmed:Citationlld:pubmed
pubmed-article:16902173lifeskim:mentionsumls-concept:C0002395lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C0333641lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C0039485lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C0205098lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C2752009lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C0332281lld:lifeskim
pubmed-article:16902173lifeskim:mentionsumls-concept:C0449258lld:lifeskim
pubmed-article:16902173pubmed:issue9lld:pubmed
pubmed-article:16902173pubmed:dateCreated2006-8-31lld:pubmed
pubmed-article:16902173pubmed:abstractTextMedial temporal lobe atrophy (MTA) is a hallmark of Alzheimer disease (AD). Its progression is often seen during the course of AD, but its frequency and risk factors remain unclear.lld:pubmed
pubmed-article:16902173pubmed:languageenglld:pubmed
pubmed-article:16902173pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16902173pubmed:citationSubsetIMlld:pubmed
pubmed-article:16902173pubmed:statusMEDLINElld:pubmed
pubmed-article:16902173pubmed:monthSeplld:pubmed
pubmed-article:16902173pubmed:issn1524-4628lld:pubmed
pubmed-article:16902173pubmed:authorpubmed-author:BarkhofFreder...lld:pubmed
pubmed-article:16902173pubmed:authorpubmed-author:ScheltensPhil...lld:pubmed
pubmed-article:16902173pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:16902173pubmed:authorpubmed-author:KorfEstherElld:pubmed
pubmed-article:16902173pubmed:issnTypeElectroniclld:pubmed
pubmed-article:16902173pubmed:volume37lld:pubmed
pubmed-article:16902173pubmed:ownerNLMlld:pubmed
pubmed-article:16902173pubmed:authorsCompleteYlld:pubmed
pubmed-article:16902173pubmed:pagination2248-52lld:pubmed
pubmed-article:16902173pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:meshHeadingpubmed-meshheading:16902173...lld:pubmed
pubmed-article:16902173pubmed:year2006lld:pubmed
pubmed-article:16902173pubmed:articleTitleWhite matter lesions are associated with progression of medial temporal lobe atrophy in Alzheimer disease.lld:pubmed
pubmed-article:16902173pubmed:affiliationDepartment of Neurology, University Medical Center St. Radboud, Nijmegen, The Netherlands. h.deleeuw@neuro.umcn.nllld:pubmed
pubmed-article:16902173pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16902173pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16902173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16902173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16902173lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16902173lld:pubmed